Literature DB >> 2828729

The role of mediastinal and multi-organ CT scans in staging presumable surgical candidates with non-small-cell lung cancer.

H Osada1, Y Nakajima, Y Taira, K Yokote, T Noguchi.   

Abstract

In order to evaluate the role of CT scan and bone scan in staging patients with non-small-cell lung cancer presumably indicated for surgery, 70 consecutive patients who underwent thoracotomy were reviewed. Most of them received mediastinal and multi-organ (brain, liver and adrenal) CT scans and a bone scan. In the most recent 40 of the 70 patients, CT findings of the mediastinal lymph nodes were compared to the pathology following complete sampling. The overall accuracy of the mediastinal CT was 60.0 per cent (12 true positive and 12 true negative), but the negative predictable value was 12/(12 + 3) or 80.0 per cent, whereas 3 were false negatives though they showed an acceptable postoperative course. Sixteen out of 21 patients with one, or at the most, three enlarged nodes detected on CT also did well postoperatively and retrospectively, were considered not to have required mediastinoscopy. A group of patients showing no, or at the most, three enlarged mediastinal lymph nodes on CT may be considered as candidates for surgery even without mediastinoscopy. Multi-organ survey by means of CT was believed cost-ineffective and omittable. Bone scan however, retrospectively detected three true positives among 20 patients with a positive uptake, so that it cannot be omitted out of hand, though further examination of this point is required.

Entities:  

Mesh:

Year:  1987        PMID: 2828729     DOI: 10.1007/BF02470635

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  17 in total

1.  The importance of mediastinal lymph node invasion by pulmonary carcinoma in selection of patients for resection.

Authors:  R A Smith
Journal:  Ann Thorac Surg       Date:  1978-01       Impact factor: 4.330

2.  Appraisal of choice and results of treatment for bronchogenic carcinoma.

Authors:  E Carlens
Journal:  Chest       Date:  1974-04       Impact factor: 9.410

3.  Role of computed tomography and mediastinoscopy in preoperative staging of lung carcinoma.

Authors:  J P Brion; L Depauw; G Kuhn; P de Fracquen; J Friberg; J Struyven
Journal:  J Comput Assist Tomogr       Date:  1985 May-Jun       Impact factor: 1.826

4.  Computed tomographic scanning of the brain in initial staging of bronchogenic carcinoma.

Authors:  R G Hooper; M F Tenholder; G H Underwood; C R Beechler; L Spratling
Journal:  Chest       Date:  1984-06       Impact factor: 9.410

5.  The value of computed tomography in staging bronchogenic carcinoma: a changing role for mediastinoscopy.

Authors:  W G Graves; M J Martinez; P L Carter; M J Barry; J S Clarke
Journal:  Ann Thorac Surg       Date:  1985-07       Impact factor: 4.330

6.  Significance of positive superior mediastinal nodes identified at mediastinoscopy in patients with resectable cancer of the lung.

Authors:  F G Pearson; N C DeLarue; R Ilves; T R Todd; J D Cooper
Journal:  J Thorac Cardiovasc Surg       Date:  1982-01       Impact factor: 5.209

7.  Evaluation of tomography and mediastinoscopy for the detection of mediastinal lymph node metastases.

Authors:  M Thermann; H Poser; K H Müller-Hermelink; H Troidl; S Brieler; V Amend; D Schröder
Journal:  Ann Thorac Surg       Date:  1984-06       Impact factor: 4.330

8.  Intracranial metastases in the initial staging of bronchogenic carcinoma.

Authors:  B J Mintz; S Tuhrim; S Alexander; W C Yang; S Shanzer
Journal:  Chest       Date:  1984-12       Impact factor: 9.410

9.  Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung.

Authors:  W P Luke; F G Pearson; T R Todd; G A Patterson; J D Cooper
Journal:  J Thorac Cardiovasc Surg       Date:  1986-01       Impact factor: 5.209

10.  The role of CT in staging radiographic T1N0M0 lung cancer.

Authors:  L R Heavey; G M Glazer; B H Gross; I R Francis; M B Orringer
Journal:  AJR Am J Roentgenol       Date:  1986-02       Impact factor: 3.959

View more
  5 in total

1.  Cost-effectiveness associated with the diagnosis and staging of non-small-cell lung cancer.

Authors:  H Osada; K Kojima; H Tsukada; Y Nakajima; K Imamura; J Matsumoto
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2001-01

2.  Omission of bone scanning according to staging guidelines leads to futile therapy in non-small cell lung cancer.

Authors:  Holger Schirrmeister; Coskun Arslandemir; Gerhard Glatting; Regine Mayer-Steinacker; Martin Bommer; Karsten Dreinhöfer; Andreas Buck; Martin Hetzel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02-28       Impact factor: 9.236

3.  Incidence and consequences of bone metastases in lung cancer patients.

Authors:  Michael Kuchuk; Christina L Addison; Mark Clemons; Iryna Kuchuk; Paul Wheatley-Price
Journal:  J Bone Oncol       Date:  2013-01-17       Impact factor: 4.072

4.  Impact of neuroimaging in the pretreatment evaluation of early stage non-small cell lung cancer.

Authors:  Garrett T Wasp; Christopher Del Prete; Jonathan A D Farrell; Konstantin H Dragnev; Gregory Russo; Graham T Atkins; Joseph D Phillips; Gabriel A Brooks
Journal:  Heliyon       Date:  2020-06-29

5.  Mortality following bone metastasis and skeletal-related events among patients 65 years and above with lung cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006.

Authors:  Nalini Sathiakumar; Elizabeth Delzell; Michael A Morrisey; Carla Falkson; Mellissa Yong; Victoria Chia; Justin Blackburn; Tarun Arora; Meredith L Kilgore
Journal:  Lung India       Date:  2013-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.